Literature DB >> 12114681

Localization of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFr) in Human Pituitary Adenomas and Nontumorous Pituitaries: An Immunocytochemical Study.

George Kontogeorgos1, Lucia Stefaneanu, Kalman Kovacs, Zi Cheng.   

Abstract

Epidermal growth factor (EGF) and epidermal growth factor receptor (EGFr) were investigated by immunocytochemistry (ICH) in 57 human pituitary adenomas and 10 nontumorous autopsy pituitaries. EGF immunoreactivity was demonstrated in 24 adenomas (42%), representing 23 functioning tumors and 1 nonfunctioning tumor of oncocytic type, and in all nontumorous pituitaries. Among 40 tumors, EGFr was found positive in 15 functioning adenomas (37.5%), representing 50% of them. The presence of both EGF and EGFr was found mainly in corticotroph adenomas (60%) and less frequently in somatotroph and lactotroph adenomas (20%). ICH on serial sections with EGF or EGFr and adrenocorticotrophic hormone (ACTH) or S-100 protein revealed that EGF and EGFr are localized specifically in corticotrophs and EGFr in stellate cells of nontumorous adenohypophysis. These results confirm the presence of EGF and EGFr in human pituitary adenomas and nontumorous pituitaries and highlight their frequent occurrence in hormone-producing adenomas. Further work is required to explore the possiblity that EGF and EGFr play a role in hormone production, release, and tumor progression.

Entities:  

Year:  1996        PMID: 12114681     DOI: 10.1007/bf02739916

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  27 in total

Review 1.  Epidermal growth factor: the receptor and its function.

Authors:  G Todderud; G Carpenter
Journal:  Biofactors       Date:  1989-03       Impact factor: 6.113

Review 2.  Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.

Authors:  W J Gullick
Journal:  Br Med Bull       Date:  1991-01       Impact factor: 4.291

Review 3.  Epidermal growth factor, its receptor, and related proteins.

Authors:  G Carpenter; J G Zendegui
Journal:  Exp Cell Res       Date:  1986-05       Impact factor: 3.905

4.  Epidermal growth factor (EGF) and monoclonal antibody to cell surface EGF receptor bind to the same chromatin receptor.

Authors:  E M Rakowicz-Szulczynska; D Otwiaska; U Rodeck; H Koprowski
Journal:  Arch Biochem Biophys       Date:  1989-02-01       Impact factor: 4.013

Review 5.  Metabolism and effects of epidermal growth factor and related growth factors in mammals.

Authors:  D A Fisher; J Lakshmanan
Journal:  Endocr Rev       Date:  1990-08       Impact factor: 19.871

6.  Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from the mitogenic response.

Authors:  L K Johnson; J D Baxter; I Vlodavsky; D Gospodarowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

7.  Distribution of epidermal growth factor binding sites in the adult rat anterior pituitary gland.

Authors:  J G Chabot; P Walker; G Pelletier
Journal:  Peptides       Date:  1986 Jan-Feb       Impact factor: 3.750

Review 8.  Epidermal growth factor and its receptor.

Authors:  G N Gill; P J Bertics; J B Santon
Journal:  Mol Cell Endocrinol       Date:  1987-06       Impact factor: 4.102

9.  Epidermal growth factor stimulates thyrotropin secretion in the rat.

Authors:  L R Altschuler; M N Parisi; L F Cageao; S R Chiocchio; J A Fernandez-Pol; A A Zaninovich
Journal:  Neuroendocrinology       Date:  1993-01       Impact factor: 4.914

10.  Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.

Authors:  S S Chaidarun; M C Eggo; M C Sheppard; P M Stewart
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

View more
  20 in total

Review 1.  Aspects of anterior pituitary growth, with special reference to corticotrophs.

Authors:  A M McNicol; E Carbajo-Perez
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.

Authors:  George Vlotides; Emily Siegel; Ines Donangelo; Shiri Gutman; Song-Guang Ren; Shlomo Melmed
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 3.  Molecular basis of pharmacological therapy in Cushing's disease.

Authors:  Diego Ferone; Claudia Pivonello; Giovanni Vitale; Maria Chiara Zatelli; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

Review 4.  Pathogenesis of non-functioning pituitary adenomas.

Authors:  Maria Chiara Zatelli
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 5.  Expression and function of ErbB receptors and ligands in the pituitary.

Authors:  Odelia Cooper; George Vlotides; Hidenori Fukuoka; Mark I Greene; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2011-10-27       Impact factor: 5.678

6.  Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.

Authors:  Antonella Sesta; Maria Francesca Cassarino; Mariarosa Terreni; Alberto G Ambrogio; Laura Libera; Donatella Bardelli; Giovanni Lasio; Marco Losa; Francesca Pecori Giraldi
Journal:  Neuroendocrinology       Date:  2019-10-16       Impact factor: 4.914

7.  ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice.

Authors:  Xiaohai Liu; Maya Kano; Takako Araki; Odelia Cooper; Hidenori Fukuoka; Yukiko Tone; Masahide Tone; Shlomo Melmed
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

8.  Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

Authors:  Odelia Cooper; Adam Mamelak; Serguei Bannykh; John Carmichael; Vivien Bonert; Stephen Lim; Galen Cook-Wiens; Anat Ben-Shlomo
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

9.  Heregulin regulates prolactinoma gene expression.

Authors:  George Vlotides; Odelia Cooper; Yen-Hao Chen; Song-Guang Ren; Yona Greenman; Shlomo Melmed
Journal:  Cancer Res       Date:  2009-04-28       Impact factor: 12.701

10.  Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells.

Authors:  George Kontogeorgos; Bernd W Scheithauer; Kalman Kovacs; Eva Horvath; Sclomo Melmed
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.